Skip to content

ASP Isotopes, Inc. ASPI Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value

Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value at other companies

Repligen logo
RepligenRGEN
$155.80
AMN Healthcare logo
AMN HealthcareAMN
$80.79-9.9%
Heartland Express logo
Heartland ExpressHTLD
$10.71-5.1%
Cal-Maine Foods logo
Cal-Maine FoodsCALM
$54.10+21.0%
Heartland Express logo
Heartland ExpressHTLD
$10.48-4.3%
Repligen logo
RepligenRGEN
$129.34

Other financials

Income statement

See full
Revenue$4.2M+279%
Gross profit$1.7M+409%
Operating income-$24.9M-213%
Net income-$7.1M+15.8%
EPS (diluted)-$0.06+50.0%

Balance sheet

See full
Cash & equivalents$211.7M+278%
Total debt$61.9M+1,787%
Total equity$289.0M+580%
Total assets$587.7M+547%

Cash flow

See full
Operating cash flow-$17.8M-460%
CapEx$6.1M+166%
Free cash flow-$23.9M-336%

Valuation

See full
Market cap$888.88M+40.0%
Enterprise value$739.08M+26.9%
P/S33×-111×

Profitability

See full
Gross margin17.6%-19.8pp
Operating margin-285.4%-102pp
Net margin-588.6%-112pp
FCF margin-244.6%-92.7pp

Returns & leverage

See full
Return on equity-95.6%-19.3pp
Debt / equity0.2×+0.1×
Current ratio4.4×-2.8×

Where this comes from

Reported directly by ASP Isotopes, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue.

The official record: ASP Isotopes, Inc.’s 10-Q, filed May 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about ASP Isotopes, Inc.'s share based compensation arrangement by share based payment award equity instruments other than options nonvested weighted average grant date fair value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ASP Isotopes, Inc.'s share based compensation arrangement by share based payment award equity instruments other than options nonvested weighted average grant date fair value?
ASP Isotopes, Inc. (ASPI) reported share based compensation arrangement by share based payment award equity instruments other than options nonvested weighted average grant date fair value of $5.36 in Q1 2026.
How has ASP Isotopes, Inc.'s share based compensation arrangement by share based payment award equity instruments other than options nonvested weighted average grant date fair value changed year-over-year?
ASP Isotopes, Inc.'s share based compensation arrangement by share based payment award equity instruments other than options nonvested weighted average grant date fair value increased by 64.4% year-over-year, from $3.26 to $5.36.
What is the long-term trend for ASP Isotopes, Inc.'s share based compensation arrangement by share based payment award equity instruments other than options nonvested weighted average grant date fair value?
Over 4 years (2021 to 2025), ASP Isotopes, Inc.'s share based compensation arrangement by share based payment award equity instruments other than options nonvested weighted average grant date fair value has grown at a 118.3% compound annual growth rate (CAGR), from $0.25 to $5.68.